Press Releases

Humacyte to Provide Investor Update on June 7

Durham, N.C. – June 4, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7 […]

Humacyte to Provide Investor Update on June 7 Read More »

We are committed to bringing first-in-class regenerative medicine products to the marketplace that will improve and save the lives of patients worldwide and transform the practice of medicine.

Humacyte to Provide Investor Update on June 7

We are committed to bringing first-in-class regenerative medicine products to the marketplace that will improve and save the lives of patients worldwide and transform the practice of medicine.

PRIVACY POLICY

EXPANDED ACCESS POLICY

CONFLICT OF INTEREST

TRANSPARENCY IN COVERAGE

(919) 313-9633